Economic Analysis of the Chemo Mouthpiece® Medical Device Suggests Potential Cost Savings of Over $15,000 per Patient Receiving Chemotherapy and Reduced Healthcare Resource Utilization

Chemo Mouthpiece®Positive

AI Analysis

Summary

Chemomouthpiece, LLC announced a peer-reviewed study demonstrating that its Chemo Mouthpiece® oral cooling device could provide cost savings exceeding $15,000 per patient and reduce healthcare resource utilization in chemotherapy treatment.

Outcome Details

Peer-reviewed study published showing modeled cost savings of over $15,000 per patient and reduced healthcare resource utilization

Importance:3/10

Sentiment:

0.60

medical devicechemotherapycost savingsoral coolingpeer-reviewed studyhealth economics

Related Companies

$HR $MDCE $IBO

Read the original article

Published by PR Newswire Pharma on July 22, 2026 3:20 PM

Read Original